SUCLG2 desuccinylation mutant gene therapy
1 paper1 finding
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals1
Outcomes
1Ovarian aging
downin mice1
1 study
Ovarian aging
downin mice1
SUCLG2 desuccinylation mutant gene therapy decreases ovarian aging in mice.
“ovarian gene therapy employing a SUCLG2 desuccinylation mutant ameliorated this condition.”
Animalsovarian gene therapy
Nature communications15 Jul 2026
Latest
1 in 12 monthsNature Communications
The SIRT5-SUCLG2 desuccinylation axis delays ovarian aging via a mitochondrial-epigenetic regulatory mechanism
Experiments in miceReproductive system